LexisNexis® | Canada

Canadian Food and Drug Legislation & Commentary, 2013/2014 Edition

This unique compilation includes the most up-to-date Food and Drugs Act and all related federal statutes and regulations. A detailed index further simplifies your research while the commentary explains the legal framework and recent developments.



Fournisseur LexisNexis Canada
Pays: Canada
Format Softcover Book
Langue de publication: English
ISBN 9780433474593
Date de publication: 2013-07-31
 
Prix: 145,00 $
Moins Plus



Produits à considérer

Advertising and Marketing Law in Canada, 4th Edition
This latest edition covers all of the hot topics in advertising and marketing law in Canada. With this guide as your reference, you can advise your clients and colleagues knowing that you have up-to-date information at your fingertips.

Canadian Health Information -A Practical Legal and Risk Management Guide, 3rd Edition
Addresses the myriad issues faced by health care facilities when it comes to gathering, maintaining and using confidential health information.

Halsbury's Laws of Canada - Food (2014 Reissue) / Gifts (2014 Reissue)
Halsbury's Food title examines the law relating to the preparation, sale and marketing of edible substances in Canada while the Gifts title examines the requirements necessary to create a valid gift, from the required intention through to delivery and acceptance.

Halsbury's Laws of Canada - Media and Postal Communications (2013 Reissue) / Medicine and Health (2013 Reissue)
The Media and Postal Communications (2013 Reissue) examines the laws impacting the print newspaper industry. The Medicine and Health (2013 Reissue) is a comprehensive national narrative of the law relating to health and medical care in Canada.

Health Law in Canada-Newsletter
This quarterly publication focuses on how the law impinges on the day-to-day tasks of health care professionals while also exploring the controversial ethical aspects of health law. Lively dialogue ensures the reader is kept up-to-date and fully aware of all significant developments.